Latest Breaking News On - Pnina fishman - Page 1 : comparemela.com

Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases

29.05.2024 - Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today reported that the International Journal of . Seite 1

Pnina fishman

Join Can-Fite s Exclusive Live Investor Webinar and Q&A Session on June 6

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, is pleased to invite investors to a.

United statesPnina fishmanMotti farbsteinRedchip companiesDrug administrationFite biopharma ltdCan fite biopharmaExecutive chairpersonChief scientific officer pnina fishmanFite biopharmaOrphan drug designationFast track designationAnnual report

Can Fite BioPharma : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON June 26, 2024 To the shareholders of Can-Fite BioPharma Ltd.: .

Tel avivUnited statesRamat ganIsrael generalD ilan cohnPnina fishmanYoseph borensteinKost forer gabbay kasiererAbraham sartaniGabbay kasiererYoseph bornsteinMotti farbsteinReinhold cohnIlan cohnYaacov goldmanTechnology commission

Can Fite BioPharma : Immediate Report of Meeting

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of.

United statesTel avivRamat ganPnina fishmanAbraham sartaniYoseph bornsteinMotti farbsteinKiryat matalonKost forer gabbay kasiererIlan cohnSecurities exchangeIsraeli securities authorityAmerican depositary shares of the companyIsraeli companies lawTel aviv stock exchangeYork stock exchange

Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at Accelerating Patient Enrolment for the Pivotal Phase 3 Advanced Liver Cancer Study

Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at Accelerating Patient Enrolment for the Pivotal Phase 3 Advanced Liver Cancer Study
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesPnina fishmanPisa university school of medicineFite biopharma ltdData monitoring committeeEuropean medicines agencyDrug administrationDepartment of radiologyAmerican cancer societyCan fite biopharmaPisa university schoolMedicine italyIndependent data monitoring committeeOrphan drugFast track statusFite biopharma